Disease study
Asthma
We used our unique combinatorial analytics approach to demonstrate the differing biological drivers of T2 and non-T2 asthma, opening new options for better patient stratification, diagnosis biomarkers, and treatments. Our findings provide promising novel indications of the mechanisms underpinning the pathogenesis of non-T2 asthma.